Methods of treating cancers with SAHA, carboplatin, and paclitaxel and other combination therapies

Details for Australian Patent Application No. 2006311829 (hide)

Owner University of Pittsburgh Merck Sharp & Dohme Corp.

Inventors Paradise, Carolyn; Belani, Chandra; Ramalingam, Suresh Sakkarai; Chiao, Judy; Frankel, Stanley

Agent Spruson & Ferguson

Pub. Number AU-B-2006311829

PCT Pub. Number WO2007/056162

Priority 60/733,951 04.11.05 US; 60/800,800 15.05.06 US

Filing date 3 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 11 October 2012

International Classifications

A61K 31/282

A61K 31/16 - Amides, e.g. hydroxamic acids

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/056162 Priority application(s): WO2007/056162

21 January 2010 Alteration of Name

  The name of the applicant has been altered to University of Pittsburgh; Merck Sharp & Dohme Corp. 2007

4 October 2012 Alteration of Name

  The name of the applicant has been altered to University of Pittsburgh; Merck Sharp & Dohme Corp. Amendments

11 October 2012 Application Accepted

  Published as AU-B-2006311829

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311830-Aminopyrimidines useful as kinase inhibitors

2006311828-Methods for promoting neurite outgrowth and survival of dopaminergic neurons